Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 7
1984 9
1985 30
1986 61
1987 53
1988 53
1989 74
1990 48
1991 68
1992 71
1993 53
1994 37
1995 49
1996 57
1997 59
1998 61
1999 65
2000 73
2001 58
2002 57
2003 58
2004 62
2005 68
2006 74
2007 76
2008 55
2009 62
2010 65
2011 70
2012 77
2013 71
2014 78
2015 73
2016 72
2017 66
2018 83
2019 83
2020 95
2021 101
2022 105
2023 88
2024 40

Text availability

Article attribute

Article type

Publication date

Search Results

2,485 results

Results by year

Filters applied: . Clear all
Page 1
Milrinone as Compared with Dobutamine in the Treatment of Cardiogenic Shock.
Mathew R, Di Santo P, Jung RG, Marbach JA, Hutson J, Simard T, Ramirez FD, Harnett DT, Merdad A, Almufleh A, Weng W, Abdel-Razek O, Fernando SM, Kyeremanteng K, Bernick J, Wells GA, Chan V, Froeschl M, Labinaz M, Le May MR, Russo JJ, Hibbert B. Mathew R, et al. N Engl J Med. 2021 Aug 5;385(6):516-525. doi: 10.1056/NEJMoa2026845. N Engl J Med. 2021. PMID: 34347952 Clinical Trial.
The treatment groups did not differ significantly with respect to the primary outcome; a primary outcome event occurred in 47 participants (49%) in the milrinone group and in 52 participants (54%) in the dobutamine group (relative risk, 0.90; 95% confidence interval [CI], …
The treatment groups did not differ significantly with respect to the primary outcome; a primary outcome event occurred in 47 participants ( …
Meta-analysis Comparing the Efficacy of Dobutamine Versus Milrinone in Acute Decompensated Heart Failure and Cardiogenic Shock.
Biswas S, Malik AH, Bandyopadhyay D, Gupta R, Goel A, Briasoulis A, Fonarow GC, Lanier GM, Naidu SS. Biswas S, et al. Curr Probl Cardiol. 2023 Aug;48(8):101245. doi: 10.1016/j.cpcardiol.2022.101245. Epub 2022 May 8. Curr Probl Cardiol. 2023. PMID: 35545181 Review.
This study aims to evaluate the difference between dobutamine and milrinone in patients presenting with acute decompensated heart failure (AHF). ...The cumulative data comparing milrinone with dobutamine indicate an overall marginal benefit of milrinone compa …
This study aims to evaluate the difference between dobutamine and milrinone in patients presenting with acute decompensated heart fai …
Milrinone Dosing and a Culture of Caution in Clinical Practice.
Chong LYZ, Satya K, Kim B, Berkowitz R. Chong LYZ, et al. Cardiol Rev. 2018 Jan/Feb;26(1):35-42. doi: 10.1097/CRD.0000000000000165. Cardiol Rev. 2018. PMID: 29045285 Review.
Milrinone is an invaluable agent in the treatment of end-stage heart failure patients who are refractory to optimal medical therapy. ...Despite these concerns, studies that comprehensively reconcile the dose-response relationship and adverse events are scarce, and no clear
Milrinone is an invaluable agent in the treatment of end-stage heart failure patients who are refractory to optimal medical therapy.
Milrinone Use in Persistent Pulmonary Hypertension of the Newborn.
Qasim A, Jain SK. Qasim A, et al. Neoreviews. 2020 Mar;21(3):e165-e178. doi: 10.1542/neo.21-3-e165. Neoreviews. 2020. PMID: 32123121 Review.
In this review, we will discuss the pathophysiology of PPHN and review the use of inotropic, lusitropic, and vasoactive agents in the management of PPHN, with particular attention to milrinone....
In this review, we will discuss the pathophysiology of PPHN and review the use of inotropic, lusitropic, and vasoactive agents in the manage …
Milrinone Dosing Issues in Critically Ill Children With Kidney Injury: A Review.
Gist KM, Goldstein SL, Joy MS, Vinks AA. Gist KM, et al. J Cardiovasc Pharmacol. 2016 Feb;67(2):175-81. doi: 10.1097/FJC.0000000000000327. J Cardiovasc Pharmacol. 2016. PMID: 26448275 Review.
Milrinone is an inotropic drug used in a variety of clinical settings in adults and children. The efficacy of milrinone in pediatric low-cardiac output syndrome after cardiac surgery is reported. ...
Milrinone is an inotropic drug used in a variety of clinical settings in adults and children. The efficacy of milrinone in ped
Nebulized Milrinone: Choosing Next Steps Wisely.
Ilonze OJ, Pang PS. Ilonze OJ, et al. J Card Fail. 2024 Feb;30(2):337-339. doi: 10.1016/j.cardfail.2023.10.480. Epub 2023 Nov 11. J Card Fail. 2024. PMID: 37952643 No abstract available.
Milrinone for persistent pulmonary hypertension of the newborn.
Bassler D, Kreutzer K, McNamara P, Kirpalani H. Bassler D, et al. Cochrane Database Syst Rev. 2010 Nov 10;2010(11):CD007802. doi: 10.1002/14651858.CD007802.pub2. Cochrane Database Syst Rev. 2010. PMID: 21069698 Free PMC article. Review.
OBJECTIVES: To assess efficacy and safety in infants with PPHN either treated with: milrinone compared with placebo or no treatment; milrinone compared with iNO; milrinone as an adjunct to iNO compared with iNO alone; milrinone compared with potential …
OBJECTIVES: To assess efficacy and safety in infants with PPHN either treated with: milrinone compared with placebo or no treatment; …
Intravenous milrinone in cardiac surgery.
Levy JH, Bailey JM, Deeb GM. Levy JH, et al. Ann Thorac Surg. 2002 Jan;73(1):325-30. doi: 10.1016/s0003-4975(01)02719-9. Ann Thorac Surg. 2002. PMID: 11834047 Review.
Phosphodiesterase inhibitors including milrinone produce positive inotropic effects by slowing the hydrolysis of cyclic adenosine monophosphate in the myocardium. ...Low-dose milrinone may have antiinflammatory properties and potentially can improve splanchnic perfu …
Phosphodiesterase inhibitors including milrinone produce positive inotropic effects by slowing the hydrolysis of cyclic adenosine mon …
2,485 results